CABA — Cabaletta Bio Balance Sheet
0.000.00%
Last trade - 00:00
- $643.54m
- $402.29m
- 35
- 26
- 79
- 44
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 136 | 109 | 122 | 107 | 241 |
Prepaid Expenses | |||||
Total Current Assets | 141 | 114 | 125 | 109 | 244 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.815 | 0.89 | 1.44 | 7.57 | 7.45 |
Other Long Term Assets | |||||
Total Assets | 141 | 115 | 126 | 117 | 254 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.15 | 5.18 | 8.38 | 9.49 | 16 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.15 | 5.18 | 8.38 | 12.4 | 17.5 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 138 | 110 | 118 | 105 | 236 |
Total Liabilities & Shareholders' Equity | 141 | 115 | 126 | 117 | 254 |
Total Common Shares Outstanding |